|
Re: Cost of PGD
Posted 8/18/2013 6:36:13 PM by bookworm
How long ago did they give you that advice? I imagine it's an opinion based on now antiquated PGD technology. Day-3 biopsies are unreliable because of mosaicism, in which embryos that correct themselves during their development can be misidentified as abnormal with the biopsy of only one cell; that cell may be abnormal but not match the bunch. It was also thought to hurt embryo quality because of manipulating the embryo and needing to freeze. However, clinics that rely on it try to biopsy at day 5, when they can take a handful of cells (instead of just one) to look for a pattern of abnormality, and they can take it from the trophectoderm (outer portion of the blast that becomes the placenta) instead of the inner cell mass (becomes the baby) which is easier on the embryo, not to mention that embryo quality and thaw survival is vastly improved by labs using vitrification. This has alleviated many of the concerns about PGD (or PGS, if you want them to look for normal pairing in all the chromosomes and not just pairs with commonly occurring errors). That said--in order to do it this way and get reliable information, you need to get your embryos to blast, which means you need good eggs and/or a really good lab. For women who don't get a lot of eggs to blast from one stim cycle, some choose to stim and bank embryos from more than one cycle to get a batch together so they can pay the expense of embryo screening once and then do a transfer. It's not for everyone, but we will be doing PGS (or CCS as CCRM calls it) because we haven't had a lot of good explanation for my RPL and repeat IVF failure, so it's unclear where to go from here. It might not be a worthwhile expense for everyone, but I'm grateful for the improvements that have made it a viable technology for getting some diagnostic criteria and helping define an individualized treatment plan. |